Event Brief
Jan 22, 2026 at 11:04 PM ET
Patent Rejected for MNC’s Cancer Drug, Generics to Follow
By The BriefBrief
India's Patent Office rejects AbbVie's patent for Venetoclax, paving the way for generics.
WHO: AbbVie
WHAT: Patent application for cancer drug Venetoclax rejected
WHEN: Jan 22, 2026 at 5:46 PM ET
WHERE: India
WHY: Lack of inventive step and no enhancement in therapeutic efficacy
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Final defendant sentenced in Zaria McKeever murder case
Zaria Mckeever
May 1, 2026 at 3:23 PM ET
Saudi Arabia delays response to UAE leaving Opec
Saudi Arabia
May 1, 2026 at 3:23 PM ET
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21435 of 21435
Same format. Every time.
Continue reading — sign in or create a free account with
